Fennec Pharmaceuticals Inc (FENC)
4.72
+0.08
(+1.72%)
USD |
NASDAQ |
Nov 21, 16:00
4.72
0.00 (0.00%)
After-Hours: 17:51
Fennec Pharmaceuticals Market Cap: 129.48M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 127.29M |
| November 19, 2024 | 117.27M |
| November 18, 2024 | 110.69M |
| November 15, 2024 | 109.45M |
| November 14, 2024 | 120.70M |
| November 13, 2024 | 122.90M |
| November 12, 2024 | 116.04M |
| November 11, 2024 | 116.86M |
| November 08, 2024 | 117.68M |
| November 07, 2024 | 119.60M |
| November 06, 2024 | 135.79M |
| November 05, 2024 | 131.67M |
| November 04, 2024 | 127.51M |
| November 01, 2024 | 119.01M |
| October 31, 2024 | 119.56M |
| October 30, 2024 | 122.58M |
| October 29, 2024 | 131.35M |
| October 28, 2024 | 129.71M |
| October 25, 2024 | 116.27M |
| October 24, 2024 | 125.59M |
| October 23, 2024 | 122.30M |
| October 22, 2024 | 124.50M |
| October 21, 2024 | 127.79M |
| October 18, 2024 | 124.50M |
| October 17, 2024 | 127.51M |
| Date | Value |
|---|---|
| October 16, 2024 | 127.51M |
| October 15, 2024 | 127.51M |
| October 14, 2024 | 124.50M |
| October 11, 2024 | 121.21M |
| October 10, 2024 | 114.90M |
| October 09, 2024 | 116.82M |
| October 08, 2024 | 123.67M |
| October 07, 2024 | 125.32M |
| October 04, 2024 | 126.69M |
| October 03, 2024 | 123.95M |
| October 02, 2024 | 126.69M |
| October 01, 2024 | 132.17M |
| September 30, 2024 | 137.11M |
| September 27, 2024 | 142.29M |
| September 26, 2024 | 140.65M |
| September 25, 2024 | 132.72M |
| September 24, 2024 | 135.18M |
| September 23, 2024 | 139.83M |
| September 20, 2024 | 143.39M |
| September 19, 2024 | 144.76M |
| September 18, 2024 | 142.84M |
| September 17, 2024 | 143.94M |
| September 16, 2024 | 142.29M |
| September 13, 2024 | 149.68M |
| September 12, 2024 | 147.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
97.29M
Minimum
Mar 18 2020
310.10M
Maximum
Dec 28 2023
190.33M
Average
189.44M
Median
Dec 22 2020
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
| Oragenics Inc | 3.301M |
Market Cap Related Metrics
| PS Ratio | 2.690 |
| Price to Free Cash Flow | 5.626 |
| Price | 4.72 |
| Earnings Yield | -2.12% |
| Operating PE Ratio | 84.38 |